( PHRM) slipped 7% in late trading Wednesday after the pharmaceutical company's fourth-quarter results missed Wall Street's expectation. Pharmion swung to a loss of $16.4 million, or 51 cents a share, from $2.6 million, or 8 cents a share, a year earlier. Excluding a charge for acquired in-process research, the company earned $4.8 million, or 15 cents a share. Analysts polled by Thomson First Call expected earnings of 21 cents a share on this basis. Pharmion's fourth-quarter sales rose to $56.4 million from $51.5 million a year ago. For 2006, the company expects net sales to be in line with 2005 sales, which totaled roughly $221.2 million. Analysts have an average estimate for sales of $239.3 million. Pharmion slipped $1.16, or 7%, to $15.50 in after-hours trading.
shares shot up after the Shanghai-based online game operator beat Wall Street's fourth-quarter earnings expectations. Earnings rose to $8.5 million, or 35 cents an American depositary share, from $4.7 million, or 19 cents a share, in the third quarter. Revenue rose 15% sequentially to $26.3 million. Analysts expected a profit of 24 cents a share and sales of $25 million. Shares of The9 gained $2.65, or 13%, to $23.55 in late trading.
shares were higher after the information-technology company's guidance overshadowed lower-than-expected fourth-quarter results. The company earned $10.4 million, or 31 cents a share, compared with $10.7 million, or 33 cents a share, a year ago. Revenue increased 16% to $261 million. Analysts polled by Thomson First Call were looking for income of 40 cents a share on sales of $270.9 million. Revenue for the full year totaled $980.3 million, up 18.5%, from a year earlier.
For 2006, ManTech projects earnings from continuing operations of $1.66 to $1.76 a share, before 11 cents in stock options expenses. The company sees full-year revenue of $1.145 billion to $1.175 billion. Analysts, on average, predict 2006 earnings of $1.66 a share and revenue of $1.143 billion. ManTech shares gained 94 cents, or 3.4%, to $28.85 in after-hours trading.
fell after the Cincinnati-based produce marketer posted a big fourth-quarter loss on charges. The company reported a loss of $19 million, or 45 cents a share, compared with year-earlier earnings of $25.1 million, or 61 cents a share. The most recent quarterly results include $23 million, or 55 cents a share, in costs related to flooding in Honduras and the consolidation of fresh-cut fruit facilities in the U.S. Midwest.
Chiquita's sales rose 30 percent to $999.1 million. Analysts polled by Thomson First Call were looking for a loss of 1 cent a share. The company also warned that the European Commission's decision to more than double its tariff on Latin American banana imports on Jan. 1 "will result in higher costs and market uncertainty." Chiquita shares dropped 90 cents, or 5%, to $17.01 in after-hours trading.
Pharmacy benefit manager
posted fourth-quarter income of $111 million, or 75 cents a share, up from $81 million, or 53 cents a share, a year earlier. Excluding a charge of 2 cents a share related to the early retirement of debt, earnings were 77 cents a share, 2 cents above analysts' estimate. Revenue increased 18% to $4.6 billion, above Wall Street's target of $4.5 billion. The company said it expects 2006 earnings to be in the range of $3.10 to $3.22 a share. Analysts are looking for earnings of $3.15 a share. Express Scripts dropped $2.76, or 2.9%, to $91.15 in after-hours trading Wednesday.